Benedicto Crespo-Facorro
#158,631
Most Influential Person Now
Researcher, psychiatrist, and professor of psychiatry
Benedicto Crespo-Facorro's AcademicInfluence.com Rankings
Download Badge
Biology
Benedicto Crespo-Facorro's Degrees
- Doctorate Medicine Complutense University of Madrid
- PhD Psychiatry University of Barcelona
Why Is Benedicto Crespo-Facorro Influential?
(Suggest an Edit or Addition)According to Wikipedia, Benedicto Crespo Facorro is a psychiatrist and professor of psychiatry with the School of Medicine at the Hospital Universitario Virgen del Rocío, Universidad de Sevilla, in Seville. Facorro is notable for his research work in the area of early psychosis and schizophrenia and for having led one of the first early psychosis early intervention programs in Spain for over two decades. Facorro is one of the only four researchers from Spain listed in the authors' collaborative network of the authors that published the greatest number of research papers on antipsychotics and schizophrenia over the last 50 years.
Benedicto Crespo-Facorro's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide Association Analysis Identifies 14 New Risk Loci for Schizophrenia (2013) (1455)
- Analysis of shared heritability in common disorders of the brain (2016) (1385)
- A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium (2016) (1125)
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium (2015) (810)
- Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects (2016) (736)
- Common genetic variants influence human subcortical brain structures (2015) (731)
- Major depression following traumatic brain injury. (2004) (691)
- The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data (2014) (646)
- Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes (2017) (517)
- Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group (2017) (423)
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia (2022) (361)
- The genetic architecture of the human cerebral cortex (2018) (355)
- Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium (2018) (343)
- Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. (2001) (242)
- Novel genetic loci associated with hippocampal volume (2017) (238)
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders (2008) (233)
- Novel genetic loci underlying human intracranial volume identified through genome-wide association (2016) (192)
- Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients (2000) (187)
- Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data. (2007) (184)
- Recalling word lists reveals "cognitive dysmetria" in schizophrenia: a positron emission tomography study. (1999) (183)
- Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. (2006) (178)
- Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. (2003) (174)
- An MRI-Based Parcellation Method for the Temporal Lobe (2000) (167)
- Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (148)
- White matter abnormalities in veterans with mild traumatic brain injury. (2012) (147)
- A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. (2006) (145)
- Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies (2014) (144)
- Alcohol misuse and mood disorders following traumatic brain injury. (2005) (138)
- Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset (2015) (137)
- Erratum: Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium (Molecular Psychiatry (2015) DOI:10.1038/mp.2015.63) (2016) (136)
- White matter integrity and cognitive impairment in first-episode psychosis. (2010) (136)
- Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study (2000) (134)
- Human Frontal Cortex: An MRI-Based Parcellation Method (1999) (131)
- No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. (2011) (130)
- Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review. (2015) (129)
- Epidemiological factors associated with treated incidence of first‐episode non‐affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis (2008) (128)
- Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study. (2012) (126)
- Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis. (2007) (126)
- Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series (2020) (124)
- Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex (2016) (120)
- Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: Findings of a randomized clinical trial in a drug-naïve population (2008) (119)
- A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. (2007) (110)
- Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. (2020) (108)
- White matter defects in first episode psychosis patients: A voxelwise analysis of diffusion tensor imaging (2010) (102)
- Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. (2019) (102)
- Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population (2009) (97)
- Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium (2017) (96)
- Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors. (2014) (94)
- Morphology of the lateral superior temporal gyrus in neuroleptic naı̈ve patients with schizophrenia: relationship to symptoms (2003) (93)
- Complement genes contribute sex-biased vulnerability in diverse illnesses (2020) (92)
- Complement genes contribute sex-biased vulnerability in diverse illnesses (2020) (92)
- Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia (2007) (92)
- The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline results (2007) (91)
- Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. (2020) (89)
- Cognitive dimensions in first-episode schizophrenia spectrum disorders. (2007) (88)
- Predictors of acute treatment response in patients with a first episode of non-affective psychosis: sociodemographics, premorbid and clinical variables. (2007) (84)
- Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. (2016) (84)
- Prefrontal cognitive functions in stabilized first-episode patients with schizophrenia spectrum disorders: A dissociation between dorsolateral and orbitofrontal functioning (2005) (84)
- Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years (2021) (84)
- Effect of Antipsychotics on Peptides Involved in Energy Balance in Drug-Naive Psychotic Patients After 1 Year of Treatment (2008) (84)
- Neural basis of novel and well‐learned recognition memory in schizophrenia: A positron emission tomography study (2001) (83)
- Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia (2008) (81)
- Neuropsychological functioning and brain structure in schizophrenia (2007) (80)
- Cerebral cortex: a topographic segmentation method using magnetic resonance imaging (2000) (76)
- Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features (2010) (75)
- Morphology of the ventral frontal cortex in schizophrenia: relationship with social dysfunction (2002) (74)
- Reduced thalamic volume in first-episode non-affective psychosis: Correlations with clinical variables, symptomatology and cognitive functioning (2007) (73)
- Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. (2009) (72)
- Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study (2017) (70)
- Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium (2017) (69)
- Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use (2010) (67)
- Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia (2009) (64)
- Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial (2010) (63)
- Gain-of-function mutations in DNMT3A in patients with paraganglioma (2018) (63)
- Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia (2012) (62)
- Using Machine Learning and Structural Neuroimaging to Detect First Episode Psychosis: Reconsidering the Evidence (2019) (62)
- Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) (2010) (60)
- Cannabis use and cognitive functioning in first-episode schizophrenia patients (2010) (59)
- Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm (2018) (59)
- A Neuregulin 1 Variant Is Associated with Increased Lateral Ventricle Volume in Patients with First-Episode Schizophrenia (2009) (59)
- An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. (2021) (58)
- A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains (2017) (57)
- The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study (2013) (57)
- Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic Treatment (2010) (57)
- 1-year follow-up study of cognitive function in first-episode non-affective psychosis (2008) (56)
- Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis (2007) (55)
- Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine (2008) (55)
- Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates (2015) (54)
- Inflammatory and immune response genes have significantly altered expression in schizophrenia (2013) (54)
- A digit symbol coding task as a screening instrument for cognitive impairment in first-episode psychosis. (2011) (53)
- Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors (2015) (53)
- Gene-environment interactions underlying the effect of cannabis in first episode psychosis. (2012) (53)
- Homocysteine and cognition: A systematic review of 111 studies (2016) (53)
- Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study. (2016) (52)
- Regional cerebral blood flow in obsessive-compulsive patients with and without a chronic tic disorder. A SPECT study. (1999) (52)
- Towards a blood-based diagnostic panel for bipolar disorder (2016) (51)
- Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice (2019) (50)
- Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice (2019) (50)
- Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: Clinical-onset implications (2010) (49)
- Sex differences in the absence of massa intermedia in patients with schizophrenia versus healthy controls (2001) (49)
- Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: Effects of antipsychotic drugs (2008) (47)
- Temporal pole morphology and psychopathology in males with schizophrenia (2004) (47)
- Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia (2010) (47)
- Immune system: A possible nexus between cannabinoids and psychosis (2014) (47)
- Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition. (2020) (47)
- Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years (2021) (47)
- A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation (2014) (46)
- No sex differences in neuropsychological performance in first episode psychosis patients (2014) (46)
- Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP) (2011) (45)
- Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women. (2016) (45)
- Diverse definitions of the early course of schizophrenia—a targeted literature review (2018) (45)
- Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis (2016) (44)
- Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder (2009) (44)
- Assessment of the increase in variability when combining volumetric data from different scanners (2009) (44)
- Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review (2015) (43)
- Homocysteine and cognition in first-episode psychosis patients (2012) (43)
- Schizophrenia Gene Expression Profile Reverted to Normal Levels by Antipsychotics (2015) (42)
- Multi-center MRI prediction models: Predicting sex and illness course in first episode psychosis patients (2017) (42)
- Effects of Family Psychoeducation on Expressed Emotion and Burden of Care in First-Episode Psychosis: A Prospective Observational Study (2010) (42)
- Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders (2006) (42)
- Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study (2013) (40)
- Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia (2018) (40)
- Novel vs. Well-learned Memory for Faces: A Positron Emission Tomography Study (2000) (40)
- Disability in bipolar I disorder: the 36-item World Health Organization Disability Assessment Schedule 2.0. (2015) (39)
- Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis (2013) (39)
- Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment. (2019) (38)
- The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients (2013) (38)
- Neuroharmony: A new tool for harmonizing volumetric MRI data from unseen scanners (2020) (37)
- Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA). (2016) (37)
- Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study (2016) (36)
- Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform disorder, non-schizophrenic non-affective psychoses and healthy volunteers. (2009) (36)
- Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review (2020) (35)
- Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group (2018) (35)
- Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone (2020) (35)
- CIBERSAM: Ten years of collaborative translational research in mental disorders. (2019) (34)
- Prediction of acute clinical response following a first episode of non affective psychosis: Results of a cohort of 375 patients from the Spanish PAFIP study (2013) (34)
- Morphometry of the superior temporal plane in schizophrenia: relationship to clinical correlates. (2004) (34)
- Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample (2010) (34)
- Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia. (2016) (33)
- Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (2015) (33)
- Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population (2021) (33)
- Tobacco smoking and its association with cognition in first episode psychosis patients (2017) (33)
- Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP) (2017) (32)
- Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis (2010) (32)
- Diez años de investigación traslacional colaborativa en enfermedades mentales: el CIBERSAM (2019) (32)
- Insight dimensions in first‐episode psychosis patients: clinical, cognitive, pre‐morbid and socio‐demographic correlates (2011) (32)
- Short-term emotional impact of COVID-19 pandemic on Spaniard health workers (2020) (32)
- Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study (2018) (31)
- A polygenic resilience score moderates the genetic risk for schizophrenia (2019) (31)
- Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone (2013) (31)
- First-episode schizophrenia patients neuropsychologically within the normal limits: Evidence of deterioration in speed of processing (2010) (31)
- Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders (2018) (31)
- Cuando la asistencia no sigue a la evidencia: el caso de la falta de programas de intervención temprana en psicosis en España (2017) (30)
- Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis (2017) (30)
- Three-year longitudinal population-based volumetric MRI study in first-episode schizophrenia spectrum patients (2013) (30)
- Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12weeks of treatment in first treated episode of psychosis (2014) (29)
- Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine (2012) (29)
- Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis (2011) (28)
- Genetic Architecture of Subcortical Brain Structures in Over 40,000 Individuals Worldwide (2017) (28)
- Alzheimer's Disease and Cancer: Current Epidemiological Evidence for a Mutual Protection (2014) (27)
- Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis (2011) (27)
- Pretreatment predictors of cognitive deficits in early psychosis (2007) (27)
- Predictors of clinical remission following a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables (2013) (27)
- Lack of insight 3years after first-episode psychosis: An unchangeable illness trait determined from first presentation? (2014) (27)
- Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment (2017) (26)
- Insular cortex thinning in first episode schizophrenia patients (2010) (26)
- Long-term effect of haloperidol, olanzapine, and risperidone on plasma prolactin levels in patients with first-episode psychosis. (2012) (26)
- Genetic Determinants of Cortical Structure (Thickness, Surface Area and Volumes) among Disease Free Adults in the CHARGE Consortium (2018) (26)
- Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition (2017) (26)
- Complement genes contribute sex-biased vulnerability in diverse disorders (2020) (25)
- Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos (2016) (25)
- Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks (2018) (25)
- Complement genes contribute sex-biased vulnerability in diverse disorders (2020) (25)
- Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients (2016) (25)
- Catechol‐O‐methyltransferase Val158Met polymorphism and clinical characteristics in first episode non‐affective psychosis (2008) (23)
- A meta‐analysis of deep brain structural shape and asymmetry abnormalities in 2,833 individuals with schizophrenia compared with 3,929 healthy volunteers via the ENIGMA Consortium (2021) (23)
- Association between the interleukin‐1 receptor antagonist gene and negative symptom improvement during antipsychotic treatment † (2006) (23)
- Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia (2022) (23)
- Inpatient Treatment for Anorexia Nervosa: A Systematic Review of Randomized Controlled Trials (2015) (22)
- Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. (2011) (22)
- The burden of disease in early schizophrenia – a systematic literature review (2020) (22)
- Multimodal Integration of Brain Images for MRI-Based Diagnosis in Schizophrenia (2019) (22)
- Grey matter volume differences in non-affective psychosis and the effects of age of onset on grey matter volumes: A voxelwise study (2015) (22)
- Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: Effects of previous suicide attempts and depression (2019) (22)
- Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study. (2017) (21)
- Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review (2016) (21)
- Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: The effect on cognitive functioning (2011) (21)
- Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial (2013) (21)
- Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison (2011) (21)
- In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis (2021) (21)
- COVID-19 Infection During Pregnancy and Risk of Neurodevelopmental Disorders in Offspring: Time for Collaborative Research (2020) (21)
- The dynamic relationship between insight and suicidal behavior in first episode psychosis patients over 3-year follow-up (2018) (20)
- Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis (2020) (20)
- Evidence for Trait Related Theory of Mind Impairment in First Episode Psychosis Patients and Its Relationship with Processing Speed: A 3 Year Follow-up Study (2016) (20)
- Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study (2017) (20)
- Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study (2019) (20)
- Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients (2018) (20)
- Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis (2020) (20)
- 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans (2021) (20)
- Understanding sex differences in long-term outcomes after a first episode of psychosis (2020) (20)
- Insular cortex morphometry in first-episode schizophrenia-spectrum patients: Diagnostic specificity and clinical correlations. (2010) (20)
- The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals (2018) (19)
- Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year (2013) (19)
- Environmental factors linked to depression vulnerability are associated with altered cerebellar resting-state synchronization (2016) (19)
- Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis (2013) (18)
- A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis (2014) (18)
- Drug discovery for psychiatric disorders using high-content single-cell screening of signaling network responses ex vivo (2019) (18)
- Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis (2008) (17)
- Lack of association between clinical and cognitive change in first-episode psychosis: the first 6 weeks of treatment. (2008) (17)
- Blood Gene Expression Profile Predicts Response to Antipsychotics (2018) (17)
- When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain. (2017) (17)
- Stopping cannabis use benefits outcome in psychosis: findings from 10‐year follow‐up study in the PAFIP‐cohort (2019) (17)
- Low-activity allele of Catechol-O-Methyltransferase (COMTL) is associated with increased lateral ventricles in patients with first episode non-affective psychosis (2007) (17)
- Aripiprazole, Ziprasidone, and Quetiapine in the Treatment of First-Episode Nonaffective Psychosis: Results of a 6-Week, Randomized, Flexible-Dose, Open-Label Comparison (2013) (17)
- Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study (2021) (17)
- Duration of active psychosis and functional outcomes in first-episode non-affective psychosis (2018) (16)
- Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review (2019) (16)
- Predicting suicidal behaviour after first episode of non-affective psychosis: The role of neurocognitive functioning (2018) (16)
- Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis (2015) (16)
- Low-density lipoprotein cholesterol and suicidal behaviour in a large sample of first-episode psychosis patients (2018) (16)
- Altered gene expression in antipsychotic-induced weight gain (2019) (16)
- Lifestyle changes and mental health during the COVID-19 pandemic: A repeated, cross-sectional web survey (2021) (16)
- Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic review (2019) (16)
- Effects of copy number variations on brain structure and risk for psychiatric illness: Large‐scale studies from the ENIGMA working groups on CNVs (2021) (16)
- Differential associations of cognitive insight components with pretreatment characteristics in first-episode psychosis (2014) (15)
- Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis (2019) (15)
- Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study (2020) (15)
- The right occipital lobe and poor insight in first-episode psychosis (2018) (15)
- No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients (2015) (15)
- Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort (2019) (15)
- Cortical Thickness Trajectories across the Lifespan: Data from 17,075 healthy individuals aged 3-90 years (2020) (15)
- Treatment of the first episode of schizophrenia: An update on pharmacologic and psychological interventions (2008) (14)
- Mental health and the SARS-CoV-2 pandemic (2020) (14)
- Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies (2017) (14)
- Cognitive functioning and negative symptoms in first episode schizophrenia: Different patterns of correlates (2008) (14)
- Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study (2017) (14)
- Longitudinal investigation of the parietal lobe anatomy in bipolar disorder and its association with general functioning (2017) (14)
- A cross-sectional and longitudinal structural magnetic resonance imaging study of the post-central gyrus in first-episode schizophrenia patients (2015) (14)
- Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment (2014) (14)
- A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia (2022) (13)
- Selective up‐regulation of cannabinoid CB1 receptor coupling to Go‐proteins in suicide victims with mood disorders (2018) (13)
- Antipsicóticos inyectables de liberación prolongada para el tratamiento de la esquizofrenia en España (2019) (13)
- Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: a systematic review and meta-analysis (2021) (13)
- Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium (2022) (12)
- Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone (2018) (12)
- Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking (2017) (12)
- Neuroanatomical Differences between First-Episode Psychosis Patients with and without Neurocognitive Deficit: A 3-Year Longitudinal Study (2013) (12)
- Childhood trauma and substance use underlying psychosis: a systematic review (2020) (12)
- Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3) (2021) (12)
- Subcortical Volume Trajectories across the Lifespan: Data from 18,605 healthy individuals aged 3-90 years (2020) (12)
- Sex differences in gene expression related to antipsychotic induced weight gain (2019) (12)
- Visual memory dysfunction as a neurocognitive endophenotype in bipolar disorder patients and their unaffected relatives. Evidence from a 5-year follow-up Valencia study. (2019) (11)
- The effects of tobacco smoking on age of onset of psychosis and psychotic symptoms in a first‐episode psychosis population (2017) (11)
- Progressive Structural Brain Changes and NRG1 Gene Variants in First-Episode Nonaffective Psychosis (2015) (11)
- Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort (2020) (11)
- Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR (2018) (11)
- Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains (2017) (11)
- Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain. (2019) (11)
- Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics (2019) (11)
- 10Kin1day: A Bottom-Up Neuroimaging Initiative (2019) (10)
- Season of birth and subclinical psychosis: Systematic review and meta-analysis of new and existing data (2015) (10)
- Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences (2017) (10)
- Exploring cellular markers of metabolic syndrome in peripheral blood mononuclear cells across the neuropsychiatric spectrum (2020) (10)
- [Transcranial magnetic stimulation in Psychiatry]. (1999) (10)
- Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences (2015) (10)
- EFFECT OF ANTIPSYCHOTIC DRUGS ON BRAIN MORPHOMETRY. A RANDOMIZED CONTROLLED ONE-YEAR FOLLOW-UP STUDY OF HALOPERIDOL, RISPERIDONE AND OLANZAPINE (2008) (10)
- Trauma and stressor-related disorders among health care workers during COVID-19 pandemic and the role of the gender: A prospective longitudinal survey. (2022) (10)
- Cognitive dysfunction in first-episode psychosis (2007) (10)
- Cortical thickness correlates of psychotic experiences: examining the effect of season of birth using a genetically informative design. (2014) (9)
- Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation. (2017) (9)
- CIBERSAM: Ten years of collaborative translational research in mental disorders (2019) (9)
- Understanding the direct and indirect costs of a first episode of psychosis program: Insights from PAFIP of Cantabria, Spain, during the first year of intervention (2018) (9)
- Suicidal Behavior and Personality Traits Contribute to Disability in First-episode Psychosis: A 1-Year Follow-up Study. (2019) (9)
- Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study (2020) (9)
- Visual hallucinations induced by the combination of prolintane and diphenhydramine. (2002) (9)
- The prognostic role of catatonia, hallucinations, and symptoms of schizophrenia in acute and transient psychosis (2019) (9)
- FC4E A PRACTICAL CLINICAL TRIAL COMPARING HALOPERIDOL, RISPERIDONE AND OLANZAPINE FOR THE ACUTE TREATMENT OF FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS (2006) (8)
- Virtual Ontogeny of Cortical Growth Preceding Mental Illness (2022) (8)
- BDNF Val66Met variants and brain volume changes in non-affective psychosis patients and healthy controls: A 3year follow-up study (2013) (8)
- Brain grey matter abnormalities in first episode non-affective psychosis patients with suicidal behaviours: The role of neurocognitive functioning (2020) (8)
- Psychosis in late life: how does it fit into current diagnostic criteria? (1999) (8)
- Sexual Regional Dimorphism of Post-Adolescent and Middle Age Brain Maturation. A Multi-center 3T MRI Study (2018) (8)
- Temporal pole morphology in first-episode schizophrenia patients: Clinical correlations (2010) (8)
- Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals (2022) (7)
- Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naïve first-episode psychosis patients (2011) (7)
- Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia (2016) (7)
- Glossary on atmospheric electricity and its effects on biology (2020) (7)
- Drug-drug Interactions between COVID-19 Treatments and Antidepressants, Mood Stabilizers/Anticonvulsants, and Benzodiazepines: Integrated Evidence from 3 Databases (2021) (7)
- One year longitudinal study of the straight gyrus morphometry in first-episode schizophrenia-spectrum patients (2012) (7)
- Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosis (2015) (7)
- Interleukin-1 receptor antagonist genotype and brain morphometry in first-episode non-affective psychosis (2008) (6)
- Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project. (2017) (6)
- Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up (2018) (6)
- Active psychosis and pro-inflammatory cytokines in first-episode of psychosis. (2020) (6)
- Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population. (2022) (6)
- Grip Strength, Neurocognition, and Social Functioning in People WithType-2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia (2020) (6)
- Lifestyle in Undergraduate Students and Demographically Matched Controls during the COVID-19 Pandemic in Spain (2021) (5)
- Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible? (2012) (5)
- Long term cortical thickness changes after a first episode of non- affective psychosis: The 10 year follow-up of the PAFIP cohort (2020) (5)
- Education and long-term outcomes in first episode psychosis: 10-year follow-up study of the PAFIP cohort (2021) (5)
- Needs of people with psychosis and their caregivers: «In their own voice». (2020) (5)
- Clinical Spanish Norms of the Stroop Test for Traumatic Brain Injury and Schizophrenia (2014) (5)
- Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium (2022) (5)
- Preserved Orbitofrontal Function in First-Episode Schizophrenia: Further Evidence From the Object Alternation Paradigm (2008) (5)
- Effect of DISC1 Polymorphisms on the Long-term Course of Neurocognitive Deficits in Non-affective Psychosis (2015) (5)
- Classification of first-episode psychosis using cortical thickness: A large multicenter MRI study (2021) (5)
- Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study (2021) (5)
- BOLD Coupling between Lesioned and Healthy Brain Is Associated with Glioma Patients’ Recovery (2021) (5)
- Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia (2022) (5)
- Aripiprazole vs Risperidone for the acute-phase treatment of first-episode psychosis: A 6-week randomized, flexible-dose, open-label clinical trial (2021) (5)
- Erratum to ‘Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients’ [Schizophr. Res. 46 (2000) 35–43] (2001) (5)
- Birth Weight and Adult IQ, but Not Anxious-Depressive Psychopathology, Are Associated with Cortical Surface Area: A Study in Twins (2015) (5)
- Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia (2022) (4)
- Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process? (2019) (4)
- Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis (2022) (4)
- Personality traits, theory of mind and their relationship with multiple suicide attempts in a sample of first episode psychosis patients: One-year follow-up study. (2019) (4)
- Prolactin, metabolic and immune parameters in naïve subjects with a first episode of psychosis (2021) (4)
- Novel genomic loci and pathways influence patterns of structural covariance in the human brain (2022) (4)
- Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders (2022) (4)
- Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3). (2021) (4)
- Efficacy and safety of olanzapine, risperidone and haloperidol in acute treatment of patients with first episode psychosis (2003) (4)
- Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case report. (2014) (4)
- Prevalence of hepatitis C in patients with non-affective psychotic disorders. (2020) (4)
- Straight gyrus morphology in first-episode schizophrenia-spectrum patients (2011) (4)
- The role of antipsychotics against COVID-19: A topic for debate (2021) (3)
- Time dependent expression of the blood biomarkers EIF2D and TOX in patients with schizophrenia (2019) (3)
- Structural brain alterations associated with suicidal thoughts and behaviors in young people: results from 21 international studies from the ENIGMA Suicidal Thoughts and Behaviours consortium (2021) (3)
- Transcriptomic and connectomic correlates of differential spatial patterning among gliomas (2022) (3)
- Disability multilevel modelling in first episodes of psychosis at 3-year follow-up (2017) (3)
- Predictive value of prolactin in first episode psychosis at ten years follow-up. (2020) (3)
- Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium (2022) (3)
- Explorer 10 Kin 1 day : A Bottom-Up Neuroimaging Initiative (2019) (3)
- Patterns of recovery course in early intervention for FIRST episode non-affective psychosis patients: The role of timing (2019) (3)
- Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort (2020) (3)
- Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain (2021) (3)
- Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain (2019) (3)
- Two schizophrenia imaging signatures and their associations with cognition, psychopathology, and genetics in the general population (2022) (3)
- COVID-19 as a unique opportunity to unravel the link between prenatal maternal infection, brain development and neuropsychiatric disorders in offspring. (2021) (3)
- Expression and Functionality Study of 9 Toll-Like Receptors in 33 Drug-Naïve Non-Affective First Episode Psychosis Individuals: A 3-Month Study (2020) (3)
- In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis (2022) (3)
- EPA-0799 - Postcentral Gyrus in Patients at First Episode of Schizophrenia: A Longitudinal Structural mri Study (2014) (3)
- Necesidades de las personas con psicosis y sus cuidadores: «en voz propia» (2020) (3)
- A network analysis approach to functioning problems in first psychotic episodes and their relationship with duration of untreated illness: Findings from the PAFIP cohort. (2020) (2)
- The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples (2022) (2)
- EARLY RESPONSE TO ANTIPSYCHOTICS AS A MARKER OF TREATMENT RESPONSE OF PSYCHOSIS (2010) (2)
- Regional temporal abnormalities in schizophrenia: A quantitative gray matter volume and cortical surface size study (2000) (2)
- Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users (2020) (2)
- Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3‐year longitudinal study (2021) (2)
- When the healthcare does not follow the evidence: The case of the lack of early intervention programs for psychosis in Spain (2017) (2)
- Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis (2021) (2)
- Predictors of weight acquisition induced by antipsychotic treatment and its relationship with age in a sample of first episode non-affective psychosis patients: A three-year follow-up study (2020) (2)
- Prevalence of metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: Baseline results from the PAFIP cohort (2022) (2)
- Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR (2020) (2)
- Prognostic significance of psychotic relapse in patients with first-episode acute and transient psychosis: New empirical support for ICD-11. (2021) (2)
- Longitudinal course of cognition in schizophrenia (2009) (2)
- The impact of COVID-19 pandemic on the psychological well-being among health care workers: A 6-month cohort longitudinal survey study (2022) (2)
- Erratum: Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia (Molecular psychiatry (2020) 25 3 (584-602)) : Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia (2020) (2)
- Planar cell polarity pathway and development of the human visual cortex (2018) (2)
- Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia (2020) (2)
- Needs of people with psychosis and their caregivers: “In their own voice” (2020) (2)
- Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers (2022) (2)
- Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort (2022) (2)
- Long-term clinical and functional outcome after antipsychotic discontinuation in early phases of non-affective psychosis: Results from the PAFIP-10 cohort (2021) (2)
- Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone (2013) (2)
- Dissecting the functional outcomes of first episode schizophrenia spectrum disorders: a 10-year follow-up study in the PAFIP cohort – CORRIGENDUM (2020) (1)
- Childhood and adolescent trauma and dissociation: The mediating role of rumination, intrusive thoughts and negative affect. (2022) (1)
- Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective study (2022) (1)
- Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis (2017) (1)
- Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis (2022) (1)
- S125. THE DYNAMIC RELATIONSHIP BETWEEN INSIGHT AND SUICIDAL BEHAVIOUR IN FIRST EPISODE PSYCHOSIS PATIENTS OVER 3-YEAR FOLLOW-UP (2018) (1)
- Entire duration of active psychosis and neurocognitive performance in first‐episode non‐affective psychosis (2020) (1)
- Cognitive therapy in early psychosis and "at risk mental state". (2007) (1)
- Direct acting antiviral treatment improves hepatitis C-related neurocognitive impaiment (2018) (1)
- Genetic architecture of subcortical brain structures in 38,851 individuals (2019) (1)
- Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort. (2022) (1)
- Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex (2016) (1)
- Long-term metabolic effect of second-generation antipsychotics in first episode of psychosis (2017) (1)
- GREY MATTER REDUCTION IN FIRST-EPISODE PSYCHOSIS: RELATIONSHIP TO DIAGNOSIS (2010) (1)
- Reelin Alterations, Behavioral Phenotypes, and Brain Anomalies in Schizophrenia: A Systematic Review of Insights From Rodent Models (2022) (1)
- Morphology of the Ventral Frontal Cortex in schizophrenia: Relationship with social dysfunction (2001) (1)
- Transdiagnostic neurocognitive deficits in patients with type 2 diabetes mellitus, major depressive disorder, bipolar disorder, and schizophrenia: A 1-year follow-up study (2021) (1)
- [Schizophrenia: a brain disease. II. Functional neuroimaging]. (2000) (1)
- Lack of differential long-term metabolic profile of aripiprazole, quetapine and ziprasidone in first episode of psychosis (2017) (1)
- Longitudinal effects of cannabis use on attentional processes in patients with first episode of psychosis (2022) (1)
- Examining the relationship between psychosis and immigration in Spain: The effect of cannabis use and language barrier in a large psychosis sample (2021) (1)
- Unraveling the relationship of loneliness and isolation in schizophrenia: Polygenic dissection and causal inference. (2020) (1)
- Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study (2022) (1)
- Verbal Memory and Voxel Based Morphometry in First Episode Non-Affective Psychosis: A Process Oriented Approach (2019) (1)
- WHITE MATTER ABNORMALITIES IN FIRST EPISODE OF PSYCHOSIS: A DTI STUDY (2009) (1)
- Transcriptomic and connectomic correlates of differential spatial patterning among glioblastomas and low-grade gliomas (2022) (1)
- GLOBAL AND REGIONAL CORTICAL THINNING IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS: RELATIONSHIPS WITH CLINICAL AND COGNITIVE FEATURES (2010) (1)
- Understanding the Influence of Personality Traits on Risk of Suicidal Behaviour in Schizophrenia Spectrum Disorders: A Systematic Review (2021) (1)
- Assessment of Neuroanatomical Endophenotypes of Autism Spectrum Disorder and Association With Characteristics of Individuals With Schizophrenia and the General Population. (2023) (1)
- Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia (2019) (1)
- [Schizophrenia: a brain disease. I. Structural neuroimaging]. (1999) (1)
- S101. DIFFERENTIATING NON-AFFECTIVE ACUTE REMITTING PSYCHOSIS (NARP) FROM SCHIZOPHRENIA IN FIRST-EPISODE PSYCHOSIS: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT (2020) (1)
- [Evaluation of verbal inhibitory control with the Stroop Test in early episodes of psychosis with the experience of traumatic events in infancy]. (2018) (1)
- Cognitive reserve as a moderator of outcomes in five clusters of first episode psychosis patients: a 10-year follow-up study of the PAFIP cohort (2021) (1)
- Insight trajectories and their impact on psychosocial functioning: A 10-year follow-up study in first episode psychosis patients. (2022) (1)
- Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort (2022) (1)
- Bridging Big Data: Procedures for Combining Non-equivalent Cognitive Measures from the ENIGMA Consortium (2023) (1)
- 5.Tomografía por emisión de positrones (2007) (1)
- Evaluación del control inhibitorio verbal con el test de Stroop en primeros episodios de psicosis con experiencia de trauma en la infancia (2018) (1)
- Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy (2017) (1)
- Two Neuroanatomical Subtypes of Schizophrenia Defined by Multi-Site Machine Learning (2020) (0)
- Poster #M1 CHILDHOOD MALTREATMENT, THE BDNF-VAL66MET POLYMORPHISM AND HIPPOCAMPAL VOLUME: FURTHER EVIDENCES FROM A MRI-TWIN STUDY (2014) (0)
- Brief greeting and shared vision (2020) (0)
- F81. AGE OF ONSET OF CANNABIS USE AND COGNITIVE FUNCTION IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS PATIENTS: 3-YEAR FOLLOW-UP OUTCOME (2018) (0)
- 85 SU-AM DTI study in First Episode of Psychosis: Relationship with cognitive domains, D Tordesillas-Gutierre, (2009) (0)
- S173. GREY MATTER VOLUME DEFFICITS IN PATIENTS WITH A FIRST EPISODE NON-AFFECTIVE PSYCHOSIS AND SUICIDE RELATED BEHAVIOUR (2018) (0)
- Classification of bipolar disorder from multi-site regional-based cortical morphology features using support vector machine technique (2022) (0)
- Screen for Cognitive Impairment in Psychiatry--Spanish Version (2019) (0)
- DISRUPTED IN SCHIZOPHRENIA 1 GENOTYPE AND RESPONSE TO ANTIPSYCHOTICS IN FIRST EPISODE PSYCHOSIS (2010) (0)
- Spanish validation of the Detachment and Compartmentalization Inventory (DCI) in a community and clinical sample. A new instrument for measuring dissociation. (2020) (0)
- P.3.a.013 Insight and clinical outcome in first episode psychosis: 1-year follow-up study (2009) (0)
- SA114POLYGENIC RISK SCORE AND METABOLIC SYNDROME PREDICTION IN PATIENTS WITH A FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS (2019) (0)
- Polygenic risk scores enhance prediction of body mass index increase in individuals with a first episode of psychosis (2023) (0)
- Responsiveness to antipsychotic treatment in first-episode psychotic patients, relation with duration of untreated psychosis (DUP) (2003) (0)
- DTI study in First Episode of Psychosis: Relationship with cognitive domains (2009) (0)
- Three Distinct Neuroanatomical Subtypes of Autism Spectrum Disorder, Revealed via Machine Learning, and Their Similarities With Schizophrenia Subtypes (2021) (0)
- THE EFFECT OF ANTIPSYCHOTICS ON PEPTIDES INVOLVED IN ENERGYBALANCE (2008) (0)
- Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study (2023) (0)
- ADDITIVE EFFECT OF NRG1 AND DISC1 GENES ON LATERAL VENTRICLE ENLARGEMENT IN FIRST EPISODE SHIZOPHRENIA (2010) (0)
- Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations (2023) (0)
- Association and epistatic analysis of white matter related genes across the continuum schizophrenia and autism spectrum disorders: The joint effect of NRG1-ErbB genes (2021) (0)
- Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study (2023) (0)
- Reactive psychoses in the context of the COVID-19 pandemic: Clinical perspectives from a case series (2020) (0)
- COVID-19 una oportunidad única para explorar la relación entre la infección prenatal materna, el desarrollo cerebral y los trastornos neuropsiquiátricos en la descendencia (2021) (0)
- 5-HT2A POLYMORPHISMS AND NEGATIVE SYMPTOMATOLOGY: EVIDENCE OF ASSOCIATION IN FIRST EPISODE PSYCHOSIS PATIENTS (2008) (0)
- P580. Two Schizophrenia Neuroanatomical Signatures From the PHENOM Consortium and Their Association With Psychopathology, Cognition, and Genetics in the Population-Level Samples (2022) (0)
- Poster #T51 BIRTH WEIGHT AND IQ ARE ASSOCIATED WITH ADULT CORTICAL SURFACE AREA: ADDITIONAL EVIDENCES BASED ON A TWIN STUDY (2014) (0)
- Mental health and the SARS-CoV-2 pandemic (2020) (0)
- Lifestyle intervention on psychotherapy and exercise and their effect on physical and psychological health in outpatients with schizophrenia spectrum disorders. A pragmatic clinical trial (2022) (0)
- Adjunctive transdermal oestradiol improves positive symptoms and general psychopathology in women with schizophrenia (2009) (0)
- Erratum to “Prefrontal cognitive functions in stabilized first-episode patients with schizophrenia spectrum disorders: A dissociation between dorsolateral and orbitofrontal functioning” [Schizophrenia Research 77 (2–3) (2005) 279–288] (2007) (0)
- VKučinskas-2001-2016 (2016) (0)
- T175. A 10-YEAR LONGITUDINAL STUDY OF GREY MATTER VOLUME IN FIRST EPISODE OF NON-AFFECTIVE PSYCHOSIS (2018) (0)
- Cervical cancer screening and psychosis: a longitudinal retrospective study comparing women with schizophrenia spectrum disorders and the general population (2022) (0)
- Making the most of biomarkers in psychiatry. (2022) (0)
- Intelligence quotient changes over 10 years: Diversity of cognitive profiles in first episode of psychosis and healthy controls (2023) (0)
- Breve salutación y visión compartida (2020) (0)
- PROGRESSION OF COGNITIVE DEFICITS ON THE FIRST YEAR AFTER SCHIZOPHRENIA ONSET (2008) (0)
- SEROTONIN TRANSPORTER POLYMORPHISMS AND EARLY RESPONSE TO ANTIPSYCHOTIC TREATMENT IN FIRST-EPISODE OF PSYCHOSIS (2008) (0)
- Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium. (2023) (0)
- Longitudinal trajectories in negative symptoms and changes in brain cortical thickness: 10-year follow-up study. (2023) (0)
- TITLE: Insight and risk of suicidal behaviour in two first-episode psychosis cohorts: effects of previous suicide attempts and depression AUTHORS: (2018) (0)
- INFLUENCE OF GENETIC VARIATIONS OF FTO AND SH2B1 GENES ON WEIGHT GAIN INDUCED BY ANTIPSYCHOTICS (2010) (0)
- W76. DECIPHERING THE DYNAMIC ROLE OF MIR-137 TARGETOME IN SCHIZOPHRENIA: TEMPORAL PROFILING AND COMORBIDITY WITH PSYCHIATRIC DISORDERS (2021) (0)
- The effect of excess weight on circulating inflammatory cytokines in drug-naïve first-episode psychosis individuals (2018) (0)
- S124. RECOVERY TRAJECTORIES IN FIRST EPISODE PSYCHOSIS PATIENTS: THE ROLE OF TIMING (2018) (0)
- Response to the letter to editor regarding “Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain” (2022) (0)
- Toward Understanding of Suicidality in a Spanish Clinical Population: Validation of the European Spanish Version of the Interpersonal Needs Questionnaire (2021) (0)
- TH77. APPLYING POLYGENIC SCORING OF SEVERE MENTAL DISORDERS TO TEST SHARED VULNERABILITY AND RISK PREDICTION IN PSYCHOTIC DISORDERS (2021) (0)
- P.3.c.056 Prolactin elevation induced by antipsychotics in first episode psychotic patients (2010) (0)
- Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia (2022) (0)
- W82. LEVERAGING GENETICS TO IMPROVE PREDICTION OF BMI INCREASE ASSOCIATED WITH PSYCHOTIC DISORDERS (2021) (0)
- Dissociable Cellular and Genetic Mechanisms of Cortical Thinning at Different Life Stages (2022) (0)
- Edinburgh Research Explorer Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex (2017) (0)
- An MR-based topographic method for the parcellation of the cerebral cortex (2000) (0)
- Breve salutación y visión compartida./ Breve salutación y visión compartida./ Brief greeting and shared vision. (2020) (0)
- Association of gene-enviroment and age of pre-onset cannabis use with age at onset of psychosis in frist-episode patients (2009) (0)
- Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. (2022) (0)
- PREDICTORS OF RELAPSE AFTER FIRST-EPISODE PSYCHOSIS DURING A 3-YEAR FOLLOW-UP (2010) (0)
- Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis (2011) (0)
- Connectome architecture shapes large-scale cortical reorganization in schizophrenia: a worldwide ENIGMA study (2023) (0)
- Structural abnormalities in the insular cortex of first-episode schizophrenia patients: A magnetic resonance imaging study (2000) (0)
- SU53. Needs of Young People With Schizophrenia/Psychosis and Their Caregivers: A Large-Scale Survey (2017) (0)
- La salud mental y la pandemia del SARS-CoV-2 (2020) (0)
- Acknowledgement to assessors (2014) (0)
- Stability of schizophrenia diagnosis in a 10‐year longitudinal study on first episode of non‐affective psychosis: Conclusions from the PAFIP cohort (2021) (0)
- Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: A 3-year follow-up comparison (2021) (0)
- Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment (2017) (0)
- F55INFLUENCE OF SCHIZOPHRENIA POLYGENIC RISK SCORES ON BRAIN SURFACE: AN EXPLORATORY STUDY IN FIRST EPISODE OF PSYCHOSIS (2019) (0)
- Corrigendum “Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain” [Psychiatry Res. 308 (2022) 114352] (2023) (0)
- Distinct patterns of premorbid social functioning in first-episode psychosis: Relationship to initial presentation (2007) (0)
- Trauma and psychosis: The mediating role of premorbid adjustment and recent stressful events in a 3-year longitudinal study (2022) (0)
- INSULAR CORTEX THINNING IN FIRST EPISODE SCHIZOPHRENIA PATIENTS. CORRELATIONS WITH CLINICAL VARIABLES, SYMPTOMATOLOGY AND COGNITIVE FUNCTIONING (2010) (0)
- 355 – Differential effect of pre-illness and current cannabis abuse on the phenotypic expression of psychosis (effect of cannabis on the expression of psychosis) (2008) (0)
- O6.7. COMMON NEUROANATOMICAL ABNORMALITIES IN FIRST EPISODE PSYCHOSIS ACROSS SEVERAL INDEPENDENT SAMPLES (2018) (0)
- Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year (2013) (0)
- Progress toward automating the application of a cerebrum parcellation method for tissue-classified human in vivo MRI (2000) (0)
- Acknowledgement to assessors (2010) (0)
- The feasibility of applying the clinical staging paradigm to the care of people with mental disorders (2013) (0)
- Plasma levels of interleukin-12 in drug-naive schizophrenic patients: Changes associated with clinical response to neuroleptic treatment (2003) (0)
- M81 SCHIZOPHRENIA POLYGENIC RISK SCORE PREDICTS ANTIPSYCHOTIC TREATMENT RESPONSE IN PATIENTS WITH FIRST EPISODE PSYCHOSIS (2019) (0)
- Leveraging genetics to improve Body Mass Index increase prediction in the first-episode of psychosis (2022) (0)
- Reduced glomerular filter rate in antipsychotic-naïve patients with first-episode psychosis (2022) (0)
- Variations in Disrupted-in-Schizophrenia 1 gene modulate long-term longitudinal differences in cortical thickness in patients with a first-episode of psychosis (2015) (0)
- MRI-based parcellation of the frontal cortex: Topographic tracing guidelines and reliability (1999) (0)
- P.507 Machine learning classification of first-episode psychosis using cortical thickness: a large multicenter magnetic resonance imaging study (2020) (0)
- 167 – Association between Dysbindin gene (DTNBP1) and psychoses in a Spanish isolate population (2008) (0)
- Predictive value of prolactin in first episode psychosis at ten years follow-up. (2021) (0)
- NORMATIVE DATA OF THE SCIP-S IN SCHIZOPHRENIA AND TYPE I BIPOLAR DISORDER (2010) (0)
- Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis. (2022) (0)
- P.3.c.071 Catechol-o-methyltransferase val158met in first episode psychosis: prognostic factor or negative trait marker? (2009) (0)
- JOP822173_supplemental_material – Supplemental material for Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study (2019) (0)
- Social anxiety disorder and temperament: Excitatory and inhibitory mechanisms on primary motor cortex in patients and healthy controls (2007) (0)
- S68. UNALTERED FRONTAL AND PREFRONTAL BRAIN RESPONSE DURING WORK MEMORY TASKS IN PATIENTS WITH A FIRST EPISODE PSYCHOSIS META-ANALYSIS STUDY (2019) (0)
- Gain-of-function mutations in DNMT3A in patients with paraganglioma (2018) (0)
- Correction: Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals. (2023) (0)
- Needs of People with Schizophrenia/Psychosis and their Caregivers: A Large Scale Survey (2017) (0)
- S17.04 Insular cortex abnormalities in schizophrenia: Clinical correlates and significance (2000) (0)
- Poster #S52 DOES SEASON OF BIRTH INFLUENCE CORTICAL THICKNESS CORRELATES OF PSYCHOTIC EXPERIENCES? A GENETICALLY INFORMATIVE MRI STUDY (2014) (0)
- T30. ASSESSING SHARED VULNERABILITY AND SEX DIFFERENCES IN PSYCHOTIC DISORDERS USING POLYGENIC SCORING (2022) (0)
- Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study (2016) (0)
- Dissociation as a Mediator of Traumatic Childhood Experiences and Ideas of Reference (2022) (0)
- Partial psychiatric hospitalization and differences in clinical outcome (2016) (0)
- Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review (2021) (0)
- A Cross-Sectional and Longitudinal Magnetic Resonance study of Insular Cortex in First-Episode Non-Affective Psicosis. Effect of Gender and Diagnostic specificity. (2009) (0)
- Método de monitorización de tratamiento antipsicótico (2016) (0)
- S70. INDIVIDUALIZED DIAGNOSIS OF PSYCHOSIS BASED ON MACHINE LEARNING FROM FUNCTIONAL MAGNETIC RESONANCE DATA USING AN EMOTIONAL AUDITORY PARADIGM (2019) (0)
- Age of onset and duration of untreated psychosis in first episode psychosis: Interaction effects between cannabis and comt (2009) (0)
- Environmental factors inducing depression alter the cerebellar resting-state synchronization. (2016) (0)
- Patterns of Structural Covariance Abnormalities and Clinical Correlations in Schizophrenia (2021) (0)
- Association study between Neuregulin-1 gene and brain structure in first episode schizophrenia (2009) (0)
- 360-DEGREE EVALUATION IN POST-GRADUATE PSYCHIATRY TRAINING (2014) (0)
- Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization (2023) (0)
- Imaging Genetics of Hallucinations (2018) (0)
- Cross-sectional and longitudinal assessment of the association between DDR1 variants and processing speed in patients with early psychosis and healthy controls. (2022) (0)
- 165 – Familial aggregation of schizotypal traits in psychosis pedigrees (2008) (0)
- CANNABIS CONSUMPTION IS RELATED TO BETTER PREMORBID ADJUSTMENT AND COGNITIVE PERFORMANCE ON FIRST EPISODE SCHIZOPHRENIA PATIENTS (2010) (0)
- Three Imaging Endophenotypes Characterize Neuroanatomical Heterogeneity of Autism Spectrum Disorder (2022) (0)
- Submission Category: Regular Research Article Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a meta-analysis. (2016) (0)
- LACK OF INFLUENCE OF COMT VAL158MET GENOTYPE ON COGNITION IN FIRST-EPISODE NON-AFFECTIVE PSYCHOSIS (2008) (0)
- Effect of Disrupted-in-Schizophrenia 1 gene on treatment response in patients with a first episode of psychosis (2016) (0)
- F124. SEX DIFFERENCES IN OUTCOME IN FIRST EPISODE PSYCHOSIS PATIENTS: A 10-YEAR FOLLOW-UP STUDY (2018) (0)
- Mecanismos cerebrales de la anhedonia en la esquizofrenia: Estudio con Tomografía por emisión de positrones (PET) de la respuesta a olores agradables y desagradables. (2001) (0)
- Brain Network Architecture Intricately Linked to Morphological Abnormalities in Major Psychiatric Disorders (2021) (0)
- M167. MACHINE LEARNING CLASSIFICATION OF FIRST-EPISODE PSYCHOSIS USING CORTICAL THICKNESS IN A LARGE MULTICENTER MRI STUDY (2020) (0)
- COVID-19 una oportunidad única para explorar la relación entre la infección prenatal materna, el desarrollo cerebral y los trastornos neuropsiquiátricos en la descendencia (2021) (0)
- P.1.a.012 Association between dysbindin gene and cerebral structures in a Spanish population (2013) (0)
- FC12A PREMORBID PREDICTORS OF NEUROCOGNITIVE FUNCTIONING IN EARLY PSYCHOSIS (2006) (0)
- Funtional characterization of 5 HT2A-mGluR2 complex at rat brain. Identification of the complexes in human peripheral blood cells (2010) (0)
- miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis. (2023) (0)
- P.3.a.002 Relationship between cannabis use and depression in a first episode of non-affective psychosis sample (2008) (0)
- Attempted Suicide, Dexamethasone, and COVID-19: Clinical Case on COVID-19 Treatments and the Implications for Mental Health. (2022) (0)
- M97. PREDICTORS OF TRANSITION TO SCHIZOPHRENIA IN BRIEF PSYCHOTIC DISORDER: FINDINGS FROM A 3-YEAR LONGITUDINAL STUDY IN THE PAFIP COHORT (2020) (0)
- DIFFERENTIAL PROFILE OF COGNITIVE FUNCTIONING IN FIRST EPISODES OF NON-AFFECTIVE PSYCHOSIS AND BIPOLAR DISORDER: A ONE-YEAR LONGITUDINAL STUDY. (2010) (0)
- Correction: Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals (2022) (0)
- 168 – Confirmation of the association of the neuregulin 1 gene (NRG1) with schizophrenia in a human isolate from northern Spain (2008) (0)
- [Biological markers of schizophrenic symptoms: functional neuroimaging]. (1998) (0)
- P.3.032 A European multicentric voxel based morphometry (VBM) study on schizophrenia and bipolar disorder (2016) (0)
- Neuroanatomical Dimensional Phenotypes of Schizophrenia: Expression in Youth With Psychosis-Spectrum Symptoms and Correlation With Cognition (2020) (0)
- Acknowledgement to assessors (2011) (0)
- P.1.a.011 Association between BDNF gene and psychosis in a Spanish population (2011) (0)
- Dr. Crespo-Facorro and Colleagues Reply (2000) (0)
- P.1.i.049 A European multicentric voxel based morphometry (VBM) study on schizophrenia and bipolar disorder (2016) (0)
- P.3.a.02l Cannabis use and clinical presentation among a sample of first episode of schizophrenia patients (2009) (0)
- F101. CANNABIS USE AND HEPATIC STEATOSIS IN PSYCHOSIS: RESULTS FROM A 3-YEAR LONGITUDINAL STUDY (2018) (0)
- Implication of Wnt /β-catenin pathway in affective disorders (2010) (0)
- A proxy measure of premorbid adjustment in psychosis for large-scale epidemiological studies and electronic health record-based research (2022) (0)
- Progress in Neuro-Psychopharmacology & Biological Psychiatry (2013) (0)
- P-1294 - Utility of the World Health Organization Disability Assessment Schedule ii in Schizophrenia (2012) (0)
- Chapter 10 5-HT2A Polymorphisms and Negative Symptoms Response to Antipsychotic Treatment: Evidence of Association in First-Episode Psychosis Patients (2012) (0)
- Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial (2022) (0)
- Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program (2020) (0)
- Poster #S1 FURTHER EVIDENCE OF THE EFFECTS OF CHILDHOOD ABUSE IN FIRST-EPISODE PSYCHOSIS AND SUBCLINICAL PSYCHOSIS (2014) (0)
- F145. WHAT ARE THE MAIN BRAIN CHANGES IN FMRI AFTER TREATMENT IN FIRST EPISODE PSYCHOSIS? A SYSTEMATIC REVIEW (2018) (0)
- 354 – Which premorbid function characteristics distinguish patients with schizophrenia from their non-psychotic siblings? (2008) (0)
- T72. VERBAL MEMORY AND VOXEL BASED MORPHOMETRY IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS: A PROCESS ORIENTED APPROACH (2018) (0)
- Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia (2022) (0)
- A generalisable normative deep learning approach for the discrimination of psychiatric disorders based on neuroanatomy (2023) (0)
This paper list is powered by the following services:
Other Resources About Benedicto Crespo-Facorro
What Schools Are Affiliated With Benedicto Crespo-Facorro?
Benedicto Crespo-Facorro is affiliated with the following schools:
